Nivor
Nivor is a synthetic opioid analgesic and antipyretic drug that was developed by the pharmaceutical company Endo Pharmaceuticals. It is a prodrug, meaning it is inactive until metabolized in the body to form norbuprenorphine, a metabolite with opioid properties. Nivor is used to treat moderate to severe pain, including postsurgical pain, cancer pain, and pain associated with injuries or chronic conditions.
The drug was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the treatment
The onset of action for Nivor is relatively rapid, with effects typically being felt within 15 to
Nivor is generally well-tolerated, but like all opioids, it can cause side effects such as nausea, vomiting,
The metabolism of Nivor to norbuprenorphine is a two-step process. First, Nivor is converted to norbuprenorphine-3-glucuronide
Nivor is not approved for use in all countries. As of now, it is primarily used in